Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | Director | June 18, 2019 | June 20, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TANDEM DIABETES CARE INC
Report date June 18, 2019 · Filed June 20, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $64.66 | Direct | 3,732 |
Reported balance
After 2019-06-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-18 · Grant · Acquired 3,732 · Balance 3,732 F1: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2: All shares subject to the option will vest in equal monthly installments over 12 months. F3: The expiration date for these options is 10 years from the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan.
F2: All shares subject to the option will vest in equal monthly installments over 12 months.
F3: The expiration date for these options is 10 years from the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2019 Filed Jun 20, 2019 22:44 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 3,732 | $0.00 Strike: $64.66 | $0.00 |
DisclosureSEC source: 0001209191-19-038314 · doc4.xml · derivative · entry 1 Valencia Richard P. · CIK 0001743728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,732 Underlying: Common Stock · 3,732 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 10,416 | $0.00 Strike: $33.12 | $0.00 |
DisclosureSEC source: 0001209191-18-059312 · doc4.xml · derivative · entry 1 Valencia Richard P. · CIK 0001743728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,416 Underlying: Common Stock · 10,416 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 22:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 1,300 | $37.75 | $49,075.00 |
DisclosureSEC source: 0001209191-18-057618 · doc4.xml · nonDerivative · entry 1 Valencia Richard P. · CIK 0001743728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,054 F1 · date: The reporting person has purchased shares of the Company's common stock. F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $37.74 and $37.75. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 21:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 1,754 | $28.50 | $49,989.00 |
DisclosureSEC source: 0001209191-18-045335 · doc4.xml · nonDerivative · entry 1 Valencia Richard P. · CIK 0001743728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,754 F1 · date: The reporting person has committed to purchase shares in connection with the Company's underwritten registered public offering of common stock. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:56 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Options · Derivative | 50,000 | $0.00 Strike: $18.86 | $0.00 |
DisclosureSEC source: 0001209191-18-038352 · doc4.xml · derivative · entry 1 Valencia Richard P. · CIK 0001743728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in 36 equal monthly installments commencing one month following the date of grant. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.